gene

SYN1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SYN1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

523Connections
0Hypotheses
5Analyses
50Outgoing
50Incoming
0Experiments
6Debates

Summary

SYN1 encodes a phosphoprotein that regulates synaptic vesicle trafficking, neurotransmitter release, and synaptic plasticity. Critically involved in AD and PD synaptic loss.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolSYN1
ChromosomeXp11.23
Functionis an important component in the neurobiology of neurodegenerative diseases.
Primary ExpressionPrimarily neuronal
PathwaysMAPK, mapk
Ensembl IDENSG00000102057
GeneCardsSYN1
Human Protein AtlasSYN1
Genomic Span~50 kb
Exon CountMultiple exons (13+)
Alternative SplicingProduces multiple isoforms (I, II, III)
Associated Diseasesaging, Als, Alzheimer, Alzheimer'S Disease
Known Drugs/Compoundsrapamycin, RAPAMYCIN
InteractionsACTB, Actin, AD, ADAM10, AKT, ALZHEIMER
KG Connections523 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (4)

Knowledge base pages for this entity

Canonical Page

SYN1 Gene

gene · 845 words

SYN1 (Synapsin-1)

gene · 978 words

Synapsin-1 Protein (SYN1)

protein · 616 words

SYN1 Gene — Synapsin I

gene · 569 words

Pathway Diagram

graph TD
    SYN1["SYN1"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
    SYN1["SYN1"] -->|"activates"| Alzheimer["Alzheimer"]
    SYN1["SYN1"] -->|"activates"| Ms["Ms"]
    SYN1["SYN1"] -->|"activates"| Ischemia["Ischemia"]
    SYN1["SYN1"] -->|"activates"| Anxiety["Anxiety"]
    SYN1["SYN1"] -->|"activates"| Inflammation["Inflammation"]
    BDNF["BDNF"] -->|"associated"| SYN1["SYN1"]
    DLG4["DLG4"] -->|"associated"| SYN1["SYN1"]
    PARP1["PARP1"] -->|"associated"| SYN1["SYN1"]
    ACTB["ACTB"] -->|"activates"| SYN1["SYN1"]
    style SYN1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (271)

TargetRelationTypeStr
ds-f2c28aed24a7provides_data_fordataset1.00
Alzheimer'S Diseaseassociated_withdisease0.95
Neuroinflammationassociated_withprocess0.95
Cognitive Impairmentassociated_withphenotype0.90
neuronsexpressed_incell_type0.90

Incoming (252)

SourceRelationTypeStr
ds-f2c28aed24a7data_indataset1.00
h-019c56c1targets_genehypothesis0.90
MBPstabilizesgene0.70
PSD95activatesgene0.70
GABRG2activatesgene0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (5)

Scientific analyses that reference this entity

Gene Co-expression Network Analysis of AD Progression Modules

neurodegeneration | 2026-04-16 | 0 hypotheses

Epigenetic reprogramming in aging neurons

neurodegeneration | 2026-04-04 | 9 hypotheses Top: 0.914

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.803

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.726

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas

neurodegeneration | 2026-04-02 | 5 hypotheses Top: 0.761

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (6)

Multi-agent debates referencing this entity

What co-expression modules are shared and unique across brain regions in AD, and

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Is TYROBP a genuine therapeutic target in AD, or is it a downstream marker of mi

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Epigenetic reprogramming in aging neurons

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Evaluate the potential of CRISPR/Cas9 and related gene editing technologies for

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

What cell types are most vulnerable in Alzheimer's Disease based on SEA-AD trans

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Cell-type specific expression patterns of neurodegeneration genes in SEA-AD

closed · Rounds: 3 · Score: 0.68 · 2026-04-02